Search

Your search keyword '"Rinfret S"' showing total 362 results

Search Constraints

Start Over You searched for: Author "Rinfret S" Remove constraint Author: "Rinfret S"
362 results on '"Rinfret S"'

Search Results

1. Outcomes With Retrograde Versus Antegrade Chronic Total Occlusion Revascularization

3. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention

4. Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions

5. TEN-YEAR STATIN ADHERENCE IN SURVIVORS OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE AMI-QUEBEC STUDY

6. CONTEMPORARY USE OF ORAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CONNECT AF+PCI STUDY

7. MYOCARDIAL INFARCTION WITH LEFT BUNDLE BRANCH BLOCK: A DEADLY DISEASE WITH A LOW RATE OF REPERFUSION TREATMENT

9. A COMPARISON OF QUALITY OF CARE OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION BY CHOICE OF REPERFUSION STRATEGY: RESULTS OF A QUÉBEC-WIDE, SYSTEMATIC FIELD EVALUATION (2013-14)

12. PRIMARY ANGIOPLASTY TREATMENT DELAYS AFTER THE IMPLEMENTATION OF A PROVINCE-WIDE PREHOSPITAL ECG PROGRAM

13. LONG-TERM STATIN USE AND ADHERENCE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE AMI-QUÉBEC REGISTRY

14. TREATMENT DELAYS ON HOURS VERSUS OFF HOURS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION ACROSS ALL HOSPITALS PERFORMING PRIMARY ANGIOPLASTY IN QUÉBEC, CANADA: RESULTS OF A THIRD FIELD EVALUATION

15. LONGTERM RECURRENT ISCHEMIC CARDIOVASCULAR EVENTS AMONG PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE AMI-QUÉBEC REGISTRY

19. 319 Body Mass Index And Waist Circumference Are Strong Predictors of High On-Treatement Platelet Reactivity in Patients Treated With Clopidogrel

21. 166 Correlation Between Cytochrome P450 2C19 Enzymatic Activity Assessed by [13C]-Pantoprazole Breath Test and Platelet Reactivity in Patients Treated With Clopidogrel After Percutaneous Coronary Intervention

23. 727 A Comparison of Outcomes of Patients with ST-Elevation Myocardial Infarction by Type of Hospital and Choice of Treatment: Results of a Québec-Wide, Systematic Field Evaluation (2008-2009)

24. 273 Bivalirudin Versus Heparin-Monotherapy in All Comers After Percutaneous Intervention: The Québec Heart-Lung Institute Experience

25. 168 Interaction Between 2C19*2 Gene Polymorphism and Proton Pump Inhibitors on Platelet Reactivity in Clopidogrel-Treated Patients

27. 295 Incidence and Predictors of Radial Failure in Patients Undergoing PCI At Québec Heart-Lung Institute, A Tertiary Care High-Volume Radial Centre

29. 336 PON1-Q192R polymorphism has no effect on platelet reactivity in patients treated with clopidogrel

31. 234 Teasing out why reperfusion therapy was not given to a substantial number of patients with ST-elevation myocardial infarction (STEMI): A classification tool developed from a province-wide systematic field evaluation

32. 005 Patients with ST-elevation myocardial infarction sent for primary percutaneous coronary intervention but who do not receive it: Results from a systematic province-wide evaluation

34. 004 The introduction of prehospital alerts and prehospital ECGs into a provincial system of care of ST-elevation myocardial infarction: Impact on treatment delays and the process of care

35. 239 Predicting high on-treatment platelet reactivity in patients with acute coronary syndromes: Role of body mass index and waist circumference

37. 232 Type of reperfusion therapy and impact on long-term survival in patients with St-elevation myocardial infarction: Insight from the AMI-Québec Study

39. 002 Centres that perform primary percutaneous coronary intervention without on-site cardiac surgery in a system of care of patients with ST-elevation myocardial infarction: Results from a systematic province-wide field evaluation

40. 438 Use of pre-hospital ECG improves time to reperfusion in STEMI patients

43. 335 Cytochrome P450 2C19*17 polymorphism offsets the negative effect of 2C19*2 polymorphism on platelet reactivity in patients treated with clopidogrel

44. 219 Reaching target lipid levels after stemi in canada: Reasons for failure

46. Smoking cessation trials

Catalog

Books, media, physical & digital resources